MHA

(redirected from MYH9)
Also found in: Medical.

MHA

(in Australia and Newfoundland, Canada) abbreviation for
(Government, Politics & Diplomacy) Member of the House of Assembly

MHA

(in Newfoundland and Australia) Member of the House of Assembly.
References in periodicals archive ?
The current NeoGenomics offering includes individual gene testing of BRCA1, BRCA2, MLH1, MSH2, EPCAM, MSH6, PMS2 genes as well as a comprehensive 73 gene panel that includes the following genes: AKT1, APC, ATM, ATR, BAP1, BARD1, BMPR1A, BRCA1, BRCA2, BRIP1, CDH1, CDK4, DKN2A, CEBPA, CHEK1, CHEK2, CTNNA1, EPCAM, ETV6, FAM175A, GALNT12, GATA2, GEN1, GREM1, HOXB13, KLLN, MEN1, MLH1, MRE11A, MSH2, MSH6, MUTYH, MYH1, MYH2, MYH3, MYH4, MYH6, MYH7, MYH8, MYH9, MYH10, MYH11, MYH13, MYH14, MYH15, NBN, NTRK1, PALB2, PIK3CA, PMS2, POLD1, POLE, PPM1D, PRSS1, PTEN, RAD50, RAD51, RAD51C, RAD51D, RET, RUNX1, SDHB, SDHC, SDHD, SMAD4, STK11, TERC, TERT, TP53, TP53BP1, VHL, WT1, XRCC2.
Mutations in the MYH9 gene encoding for the nonmuscle myosin heavy chain IIA result in a spectrum of macrothrombocytopenia disorders with neutrophil inclusions referred to as MYH9 disorders.
Doron Behar of Rambam Medical Center, discovered highly informative DNA markers in the MYH9 gene.
Velocardiofacial syndrome, MYH9 gene-related disorders and Jacobsen syndrome (JBS) are well-known inherited syndromes of thrombocytopenias, in which platelets are increased in size and affected probands have unique phenotypic expressions such as cardiovascular, renal, skeletal and gonadal anomalies [2].
A mutation in the MYH9 gene that encodes for non-muscle myosin heavy chain, a cytoskeletal protein in platelets, may be responsible for the abnormal platelet diameter.